Leg lymphedema caused by iliopectineal bursitis associated with destruction of a rheumatoid hip joint: A case report

被引:6
作者
Kuroyanagi, Gen [1 ,2 ]
Yamada, Kunio [3 ]
Imaizumi, Tsukasa [3 ]
Mizutani, Jun [1 ]
Wada, Ikuo [1 ]
Kozawa, Osamu [2 ]
Tokuda, Haruhiko [4 ]
Otsuka, Takanobu [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi 4678601, Japan
[2] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan
[3] Komaki City Hosp, Dept Orthoped Surg, Komaki, Aichi 4858520, Japan
[4] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi 4748511, Japan
关键词
iliopectineal bursa; rheumatoid arthritis; total hip arthroplasty; rheumatoid hip joint; leg lymphedema; ILIOPSOAS BURSA; ARTHRITIS; TACROLIMUS; THERAPY; PATIENT;
D O I
10.3892/etm.2013.1243
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study describes a case of leg lymphedema due to iliopectineal bursitis associated with rheumatoid arthritis (RA), which was satisfactorily controlled by surgery and combination therapy with methotrexate (MTX) and tacrolimus. A 68-year-old male, who had a six-year history of RA, developed an iliopectineal bursa associated with destruction of the hip joint. The mass gradually increased in size, and there was swelling in his right lower extremity. The patient was subsequently hospitalized with increasing right hip pain and leg edema. A colorless transparent lymph fluid leaked from his leg, and leg lymphedema was thus diagnosed. The patient also had a 20-year history of myelodysplastic syndrome. Therefore, the extensive or total resection of the bursa was considered to be too invasive, so a partial bursal excision was performed via an anterior approach. Following the partial bursal excision, total hip arthroplasty (THA) was performed using the Hardinge approach. The leg lymphedema disappeared following the surgery, and the iliopectineal bursa was no longer enlarged. MTX and tacrolimus were postoperatively administered to strictly control the RA. The RA was subsequently well controlled, without any increases in the levels of inflammatory markers, such as C-reactive protein and matrix metalloproteinase-3. This case demonstrated that iliopectineal bursitis was resolved following THA, without complete excision of the intrapelvic bursa, and that strict RA control led to a good clinical course without recurrent inflammation of the bursa. Similar procedures may be beneficial in other patients contraindicated for resection of the entire bursa.
引用
收藏
页码:887 / 890
页数:4
相关论文
共 22 条
  • [1] The iliopsoas bursa in man
    Chandler, SB
    [J]. ANATOMICAL RECORD, 1934, 58 (03): : 235 - 240
  • [2] RHEUMATOID SYNOVIAL CYST OF THE HIP - REPORT OF 3 CASES
    COVENTRY, MB
    POLLEY, HF
    WEINER, AD
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1959, 41 (04) : 721 - &
  • [3] The efficacy and safety of tacrolimus in rheumatoid arthritis
    Dutta, Shouma
    Ahmad, Yasmeen
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (06) : 283 - 291
  • [4] Fricke JI, 1834, J CHIRURGIE AUGEN HE, V21, P223
  • [5] JONES PBB, 1993, BRIT J RHEUMATOL, V32, P832
  • [6] ILIOPSOAS BURSA OF THE RHEUMATOID HIP-JOINT - A CASE-REPORT AND REVIEW OF THE LITERATURE
    KATAOKA, M
    TORISU, T
    NAKAMURA, M
    UCHIDA, K
    [J]. CLINICAL RHEUMATOLOGY, 1995, 14 (03) : 358 - 364
  • [7] Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients
    Kawai, S
    Yamamoto, K
    [J]. RHEUMATOLOGY, 2006, 45 (04) : 441 - 444
  • [8] Kelly PA, 1987, AM J HEALTH-SYST PH, V52, P1569
  • [9] FK-506, A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM A STREPTOMYCES .2. IMMUNOSUPPRESSIVE EFFECT OF FK-506 INVITRO
    KINO, T
    HATANAKA, H
    MIYATA, S
    INAMURA, N
    NISHIYAMA, M
    YAJIMA, T
    GOTO, T
    OKUHARA, M
    KOHSAKA, M
    AOKI, H
    OCHIAI, T
    [J]. JOURNAL OF ANTIBIOTICS, 1987, 40 (09) : 1256 - 1265
  • [10] Rational use of new and existing disease-modifying agents in rheumatoid arthritis
    Kremer, JM
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) : 695 - 706